微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 20.71% | -46.4% | 352.47% | 123/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 4.58% | -88.81% | -83.78% | 127/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 28.22% | -31.95% | -26.58% | 111/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 38.44% | -5.18% | -0.53% | 95/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 38.64% | -2.2% | -5.57% | 95/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 40.92% | 5.54% | -1.33% | 89/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 41.47% | -2.64% | 2.29% | 92/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 40.54% | 0.31% | 2.6% | 92/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 39.51% | 5.14% | 1.91% | 97/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 38.77% | 0.83% | -8.98% | 93/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 42.59% | 2.47% | 5.39% | 92/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 40.41% | -0.69% | 7.55% | 93/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 37.58% | -6.62% | -2.27% | 99/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 38.45% | -4.73% | -7.5% | 94/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 41.57% | 8.84% | 2.14% | 96/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 40.69% | 4.08% | 1.13% | 91/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 40.24% | 4.18% | -0.3% | 98/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 40.36% | 7.55% | 5.68% | 85/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 38.19% | 7.87% | -2.32% | 108/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 39.1% | 7.28% | 1.23% | 91/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 38.62% | 3.61% | 2.93% | 99/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 37.52% | -2.97% | 5.99% | 85/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 35.4% | -16.65% | -2.86% | 112/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 36.45% | -16.54% | -2.23% | 81/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 37.28% | -13.19% | -3.61% | 96/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 38.67% | -2.86% | -8.95% | 61/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 42.47% | 1.44% | -2.73% | 90/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 43.67% | 3.89% | 1.69% | 45/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 42.94% | -0.66% | 7.86% | 56/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 39.81% | -12.27% | -4.92% | 40/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 41.87% | 4.22% | -0.38% | 76/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 42.03% | 12.66% | -2.76% | 33/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 43.22% | 17.11% | -4.75% | 38/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 45.38% | 25.27% | 12.95% | 28/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 40.18% | 9.98% | 7.69% | 76/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 37.31% | 2.1% | 1.09% | 36/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 36.91% | 3% | 1.88% | 45/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 36.23% | -0.45% | -0.83% | 36/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 36.53% | 4.95% | -0.03% | 64/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 36.54% | 3.64% | 1.98% | 32/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 35.83% | 1.66% | -1.53% | 39/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 36.39% | 3.39% | 4.54% | 29/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |